In this report (download here) , Q1 2023 Global Biopharma Market Trends and News, we cover the key Biotech/Pharma trends and developments in seven regions (US, Europe, Japan, India, China, Latin America, and Africa) for the first quarter of 2023. We have also covered the major news and developments of the top ten companies in […]

Read more

KYBORA’s mission is to help life science companies achieve enduring success. Khai’s addition to our team allows us to provide additional value to our clients in China and Asia.

Read more

KYBORA is pleased to announce that its client Megalabs has acquired acquired Fr!ska.

Read more

KYBORA is pleased to announce the licensing of Daewoong’s development stage IPF therapy (Bersiporocin) to CS Pharmaceuticals for the Greater China region.

Read more

KYBORA and its Chinese translation (pronounced KAI-BO-RUI) have both been granted official trademark status by the People’s Republic of China.

Read more

KYBORA is please to announce that its client Pint Pharma has completed an agreement to commercialize Orladeyo in Latin America

Read more

Princeton, NJ – October 12th, 2021 KYBORA is pleased to announce that Howard Lei (MBA, MS-IT, PMP) has joined its team as Senior Advisor, responsible for expanding KYBORA’s operations in China (Shanghai).  Howard is an experienced pharmaceutical executive with over 20 years of consulting and industry experience in China and the US with companies such […]

Read more

KYBORA is pleased to announce that Dr. Leonid Parshenkov, MD has joined its team as Senior Advisor, responsible for expanding KYBORA’s operations in Russia, CIS/CEE, and Africa. Leonid is a seasoned pharma leader with broad international experience. He worked as the General Manager (GM) of Solvay and Abbott in Russia, then assumed the role of […]

Read more

Download full presentation here

Read more

Recently, KYBORA Managing Director Jean Chatellier had an opportunity to share insights with industry leader Sejelas’ Ask the Experts Interview Series about KYBORA, our clients, what led him to join the company, and what sets us apart.  See the full article here: https://sejelas.com/jean-chatellier/

Read more

TYPE & ENTER: